Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART: Definity Stress Echo in Menopausal Women
NCT00162370Phase 4Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Apr 2004
- Primary completion
- Sep 2012
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perflutren lipid microspheres in coronary artery disease (CAD), sponsored by Lantheus Holdings, Inc. Primary endpoint: Major Adverse Cardiac Events at 5 years. Started Apr 2004; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00162370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162370.